Mesenchymal stem cell homing towards cancer cells is increased by enzyme activity of cathepsin D
-
Add time:08/16/2019 Source:sciencedirect.com
Mesenchymal stem cells home towards inflammatory microenvironments, such as the tumour stroma, where they have been shown to have both pro- and anti-tumorigenic effects. Here, we demonstrate that the aspartic acid protease cathepsin D is part of the chemoattraction process. Using a Boyden chamber co-culture system, the migration of the mesenchymal stem cells and their invasion through Matrigel increased in the presence of breast cancer MDA-MB-231 cells, colon cancer HT29 cells or their conditioned media. Mesenchymal stem cell movement was reduced by protease inhibitors of matrix metalloproteinases and by pepstatin A, an inhibitor of cathepsin D. We confirmed a role for cathepsin D through addition of recombinant protein, upregulation of cathepsin D release using chloroquine and knockdown of cathepsin D expression. While all cell types expressed active cathepsin D, enzymatically inactive precursor procathepsin D was expressed only at low levels by mesenchymal stem cells. Expression in mesenchymal stem cells was increased following co-culture with cancer cells. The chemoattractive effect of cathepsin required its enzymatic activity, but not changes in mesenchymal stem cell proliferation or adhesion rates. In conclusion, cathepsin D and its precursors enhance mesenchymal stem cell homing towards tumour sites, most likely by enzymatic mechanisms.
We also recommend Trading Suppliers and Manufacturers of CATHEPSIN G FROM HUMAN LEUKOCYTES (cas 107200-92-0). Pls Click Website Link as below: cas 107200-92-0 suppliers
Prev:Full length articleFunctional analysis and gene expression profiling of extracellular cathepsin Z in red sea bream, Pagrus major
Next:Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original articleIntracardiac administration of neutrophil protease cathepsin G activates noncanonical inflammasome pathway and promotes inflammation and pathological remodeling in non-injured heart08/21/2019
- Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human Cathepsin G08/20/2019
- Full length article2’,3-dihydroxy-5-methoxybiphenyl suppresses fMLP-induced superoxide anion production and cathepsin G release by targeting the β-subunit of G-protein in human neutrophils08/19/2019
- PaperThe degradation of bovine and human prothrombin by human polymorphonuclear leukocyte cathepsin g08/18/2019
- Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases08/17/2019
- Full length articleFunctional analysis and gene expression profiling of extracellular cathepsin Z in red sea bream, Pagrus major08/15/2019
- PaperAn enzyme immunoassay of human polymorphonuclear leukocyte cathepsin G08/14/2019
- The role and mechanism of cathepsin G in dermatomyositis☆08/13/2019
- ArticleCathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation08/12/2019


